The Knowledge Hub for Medical Imaging Professionals: Transforming Radiology with Structured Reporting, Data-Driven Approaches and Multicentric Research

Access breakthrough research, innovative case studies and collaborative projects advancing radiology worldwide. Dive into our activities and product updates, and learn who we are as a company and as a team.

Mrs. Kelie Luby joins Mint Medical's team

Mrs. Kelie Luby will join Mint Medical’s team from January 2017 as new Vice President Clinical Trials Software and will be introduced at the upcoming RSNA congress in Chicago.

Kelie is an experienced medical scientist and communicator with more than 18 years of clinical trial experience, including 12 years in the Imaging Contract Research Organization (CRO) space. Based on the US East Coast, Kelie extends our expertise in medical imaging analysis, implementation of all standard as well as complex scientific assessment criteria used in oncology and other indications.

She has trained 100’s of medical experts, including radiologists, nuclear medicine physicians, oncologists and other specialists, on implementation of assessment criteria for central review of clinical trial data as well as investigators and other clinical site staff. She has hands on experience in several imaging software platforms including mint Lesion™ as well as other Imaging CRO proprietary platforms.

Related Resources

Related Resources

Assessment time halved: Importance of a good tumor response assessment tool in clinical site reads

The Clinical Research Imaging Core (CRIC) of the University of Wisconsin Carbone Cancer Center (UWCCC) recently published a poster at the AACI CRI…

6 years of Mint at University Hospital Basel - Interview with PD Dr. Tobias Heye

Since the end of 2011, mint Lesion™ has been in use at the University Hospital in Basel, Switzerland, – initially merely as a tool for clinical…

4 Questions – 4 Answers // Imaging in Clinical Trials

Mint Medical, Inc. Vice President of Clinical Trials, Kelie Luby Discusses Advances in Imaging Analysis in Clinical Trials and What’s Next for Mint…